| Director Dealings Summary - Week Ended May 22 | ||||||||||||
| Company | Name | Position | Number of Shares | Resulting Holding | *Note | GBP Value | ||||||
| BUYS | ||||||||||||
| Topps Tiles | Matthew Williams | CEO | 1 million | 1.7 million | 1,270,000 | |||||||
| Countrywide | Alison Platt | CEO | 41,700 | 41,700 | Appointed CEO in September 2014. | 248,000 | ||||||
| Rank Group | Henry Birch | CEO | 100,000 | 100,000 | Same day as Rank said it expects full year results to meet management expectations. | 205,000 | ||||||
| Homeserve | John Gibson | Chairman | 40,000 | 115,000 | Day after reporting higher profit and said it would pay a special dividend of GBP97 million. | 172,000 | ||||||
| Sage Group | Jonathan Howell | Non-Executive Director | 18,167 | Undisclosed | 103,000 | |||||||
| AG Barr | Stuart Lorimer | CFO | 14,000 | 1.1 million | 87,000 | |||||||
| Homeserve | Ben Mingay | Non-Executive Director | 20,000 | 40,000 | Day after reporting higher profit and said it would pay a special dividend of GBP97 million. | 86,000 | ||||||
| Inspired Capital | Jeremy Coombes | Interim CEO | 535,000 | 2.9 million | 75,000 | |||||||
| Rank Group | Clive Jennings | CFO | 25,000 | 25,000 | Same day as Rank said it expects full year results to meet management expectations.. | 51,000 | ||||||
| STM Group | Michael Riddell | Chairman | 137,000 | Undisclosed | Week after STM said it made good start to 2015 and said trading so far this year is in line with its expectations. | 49,000 | ||||||
| Homeserve | Stella David | Non-Executive Director | 10,450 | 28,138 | 2 days after reporting higher profit and said it would pay a special dividend of GBP97 million. | 45,000 | ||||||
| Mitchells & Butlers | Eddie Irwin | Non-Executive Director | 10,000 | 30,000 | 45,000 | |||||||
| Amara Mining | John McGloin | Chairman | 271,249 | 1.6 million | 41,000 | |||||||
| McBride | Chris Smith | CFO | 25,657 | 25,657 | Appointed in January. | 24,000 | ||||||
| Oxford Biomedica | Tim Watts | CFO | 194,174 | 5.8 million | 19,000 | |||||||
| Symphony Environmental | Michael Stephen | Deputy Chairman | 151,000 | 933,998 | 15,000 | |||||||
| Symphony Environmental | Michael Laurier | CEO | 150,000 | 23 million | 14,000 | |||||||
| Verona Pharma | David Ebsworth | Chairman | 300,000 | 3.6 million | Week after Verona Pharma posted a widened pretax loss for 2014. | 11,000 | ||||||
| Lekoil | Greg Eckersley | Non-Executive Director | 50,000 | 2.8 million | Week after Lekoil said its pretax loss narrowed as administrative and finance costs fell. | 10,000 | ||||||
| Oxford Biomedica | Andrew Heath | Non-Executive Director | 100,000 | 1.1 million | 10,000 | |||||||
| Mortgage Advice Bureau | Lucy Tilley | CFO | 4,500 | 4,500 | Appointed in March. Was previously a director in Canaccord Genuity's corporate broking team, which worked on company's AIM listing. | 9,900 | ||||||
| Airea | Roger Salt | CFO | 58,738 | 228,738 | 9,000 | |||||||
| Symphony Environmental | Ian Bristow | CFO | 100,000 | 1.2 million | 9,000 | |||||||
| K3 Business Technology | Brian Davies | CFO | 2,253 | 9,537 | Bought shares from CEO David Bolton | 5,600 | ||||||
| Verona Pharma | Biresh Roy | CFO | 150,000 | 900,000 | Week after Verona Pharma posted a widened pretax loss for 2014. | 5,000 | ||||||
| Symphony Environmental | Nirj Deva | Chairman | 50,000 | 363,925 | 4800 | |||||||
| Verona Pharma | Jan-Anders Karlsson | CEO | 135,000 | 2.9 million | Week after Verona Pharma posted a widened pretax loss for 2014. | 4,700 | ||||||
| Symphony Environmental | Nicholas Clavel | Non-Executive Director | 50,000 | 550,000 | 4,500 | |||||||
| SELLS | ||||||||||||
| Glencore | William Macaulay | Non-Executive Director | 28 million | 42 million | Sold by FR Galaxy Holdings, an investment vehicle connected to Macaulay. | 84,000,000 | ||||||
| Moneysupermarket | Simon Nixon | Founder & non-executive deputy chairman | 20 million | 69.8 million | The amount of shares sold is at the top end of the range. Credit Suisse, the sole bookrunner on the placing, said it would sell a stake of between 2.8% and 3.7% on behalf of Nixon, who retains a 12.8% holding. | 56,000,000 | ||||||
| Merlin Entertainments | Nick Mackenzie | Manager | 440,000 | 1.5 million | Same day as Merlin reported growth in revenue boosted by new site openings, features and good weather, as it continues strategic expansion plans. | 2,000,000 | ||||||
| Countrywide | Grenville Turner | Chairman | 300,000 | 171,524 | 1,800,000 | |||||||
| Hays | Paul Venables | CFO | 750,000 | 953,014 | 1,200,000 | |||||||
| Sthree | Justin Hughes | Corporate Executive Officer | 267,500 | 390,867 | Has sold parcels of shares in quick succession since May 12. | 1,000,000 | ||||||
| Euromoney | Peter Ensor | Chairman | 20,421 | 175,918 | Same day as interim ex-dividend date. | 245,000 | ||||||
| Bloomsbury Publishing | Nigel Newton | CEO | 132,651 | 1.1 million | Day after Bloomsbury posted a small rise in pretax profit and said trading in its current year has been good across all of its divisions. | 232,000 | ||||||
| ITV | David Osborn | HR Director | 35,900 | Nil | 97,000 | |||||||
| Rolls-Royce | Jason Smith | Divisional CEO | 2,850 | 19,582 | 29,000 | |||||||
| K3 Business Technology | David Bolton | CEO | 2,253 | 994,961 | Sold shares to CFO Brian Davies. | |||||||
| *Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. | ||||||||||||
| When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director | ||||||||||||
| Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam | ||||||||||||
| Copyright 2015 Alliance News Limited. All Rights Reserved. | ||||||||||||
12 Jan 2015 11:55
Verona Pharma doses first volunteers in 'RPL554' asthma trial
Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clinical trial, which analysts said was a significant step. The AIM company said the study's main objective was to confirm the safety, tolerability and br
Read more